Bluejay Diagnostics Inc.
BJDX | NASDAQ
$1
+$0.09 (+9.65%)
At close: Sep 22, 2026, 4:00 PM ET
$1.02
+$0.02 (+2.00%)
After-hours:
Sep 22, 2026, 6:27 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | 249.04K | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | 200.13K | n/a | 157.04K |
Gross Profit | n/a | n/a | n/a | 48.91K | n/a | -157.04K |
Operating Income | -6.95M | -7.17M | -10.31M | -9.32M | -3.23M | -1.2M |
Interest Income | 97.56K | 145.82K | 164.9K | 89.67K | 513.3K | 143.67K |
Pretax Income | -6.85M | -7.72M | -9.95M | -9.3M | -3.49M | -1.16M |
Net Income | -6.85M | -7.72M | -9.95M | -9.3M | -3.73M | -1.13M |
Selling & General & Admin | 3.91M | 3.7M | 4.6M | 5.21M | 2.08M | 669.14K |
Research & Development | 3.05M | 3.47M | 5.71M | 4.15M | 1.15M | 527.25K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | -157.04K |
Operating Expenses | 6.95M | 7.17M | 10.31M | 9.37M | 3.23M | 1.04M |
Interest Expense | 839 | 823.03K | n/a | n/a | 367.46K | 27K |
Selling & Marketing Expenses | n/a | 8.3K | 283.44K | 451.42K | 289.73K | 73.02K |
Cost & Expenses | 6.95M | 7.17M | 10.31M | 9.57M | 3.23M | 1.2M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 449.04K | 45.85K | 34.27K | 31.51K | 31.43K | 19.84K |
Shares Outstanding (Diluted) | 449.04K | 45.85K | 34.27K | 31.51K | 31.43K | 19.84K |
EPS (Basic) | -15.25 | -456.76 | -290.48 | -292.88 | -118.68 | -56.76 |
EPS (Diluted) | -15.25 | -456.76 | -290.48 | -292.88 | -118.68 | -56.76 |
EBITDA | -6.68M | -6.7M | -9.17M | -8.99M | -2.98M | -1.04M |
EBIT | -6.85M | -6.89M | -9.95M | -9.3M | -3.12M | -1.2M |
Depreciation & Amortization | 170.68K | 199.1K | 780.96K | 306.37K | 145.72K | 157.04K |
Add to Watchlist
Select watchlists to add or remove BJDX